登录查看更多内容

??The MP Insight: Helping Decision-Makers Drive Smarter Pharma Innovation

Malvern Panalytical Pharmaceuticals

Supporting you in each stage of discovery, development and manufacture of (bio)pharmaceuticals.

发布日期: 2025年3月4日

Welcome to Pharma Insight by Malvern Panalytical, your source for the latest trends, breakthroughs, and insights in pharmaceutical analytics. Each month, we’ll explore topics that matter to pharma professionals like you, from regulatory shifts to the latest in precision technology ??

In today’s fast-paced pharmaceutical landscape, success isn’t just about adopting the latest analytical technologies—it’s about optimizing every stage of the workflow, from early-stage research and drug discovery to development, manufacturing, and regulatory compliance. ? ?

Whether refining analytical techniques, ensuring product quality, or accelerating time-to-market, efficient, data-driven decision-making is the key to innovation.?

In this issue, we focus on real-world innovations that can help your business operate more efficiently while maintaining the highest quality standards.?

Let's discover together the main recent trends for Research and Discovery

?? Key Trends Impacting QA, QC & Pharma Research and Discovery?

Regulatory Pressures Are Increasing:? FDA and EMA guidelines require more precise and reproducible analytical workflows—are your current methods compliant??

Smaller Companies Need Scalable, Cost-Effective Solutions:? Not every organization has the resources of a pharma giant—how can small and mid-sized companies improve efficiency without stretching their budgets??

?AI & Automation in Analytical Science:? From automated XRD systems to AI-driven nanoparticle characterization, the industry is shifting towards faster, smarter, and more reproducible solutions.?

?? Smarter Drug Discovery: Reduce Timelines, Increase Accuracy?

Accelerating Membrane Protein Analysis??

Membrane proteins, including GPCRs are key markets, accounting for around 30% of all drug targets in drug discovery, but traditional methods are slow limiting biomolecular interaction analysis.?

WAVEsystem’s grating-coupled interferometry (GCI) tech enables faster screening while reducing target protein degradation, revealing interactions unseen by other technologies?

Join Dr. Edoardo Fabini/Evotec to learn how his team hit screened a library of 5,500 fragments against six targets in just three weeks.?

?? Find out more

Are you working with Vaccines and Drug Delivery? Check out faster ways to meet the industry demand

?? Advances in Vaccines & Drug Delivery: Meeting Industry demand faster?

Viral Vector Characterization with NanoSight Pro?

As viral vectors play an increasing role in gene therapies and vaccine development, ensuring their quality, stability, and efficacy is an important factor.?

Precise characterization is vital to optimizing delivery, performance, and regulatory compliance across both therapeutic and prophylactic applications.?

NanoSight Pro’s fluorescence detection provides more precise, real-time viral vector analysis, ensuring regulatory compliance and optimizing scale-up efficiency.?

?? Learn more

?? Enhancing Stability & Compliance in Drug Formulations?

Is It Time to Bring XRD In-House??

Many pharmaceutical labs outsource XRD analysis due to the complexity of traditional systems.?

Aeris, the world’s first compact XRD system, is budget-friendly, easy to use, and fully automated, making high-precision XRD accessible in-house—reducing outsourcing costs.?

?? Meet Aeris

A Cost-Effective Alternative for Elemental Analysis?

XRF spectroscopy is becoming an increasingly popular choice for pharmaceutical labs, offering faster, greener, and safer elemental analysis compared to ICP workflows.?

?? Find out why pharma leaders are turning to XRF